UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Clinical cancer research, 2015-08, Vol.21 (15), p.3561-3568

2015

Volltextzugriff (PDF)

Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes

Steroids, 2016-10, Vol.114, p.48-58

2016

Volltextzugriff (PDF)

Progesterone action in breast, uterine, and ovarian cancers

Journal of molecular endocrinology, 2015-04, Vol.54 (2), p.R31-R53

2015

Volltextzugriff (PDF)

Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer

Breast cancer research : BCR, 2020-05, Vol.22 (1), p.39-23, Article 39

2020

Volltextzugriff (PDF)

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells

PloS one, 2012-03, Vol.7 (3), p.e32783

2012

Volltextzugriff (PDF)

Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for developing breast cancer

Steroids, 2023-12, Vol.200, p.109329-109329, Article 109329

2023

Volltextzugriff (PDF)

Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates

Endocrinology (Philadelphia), 2019-02, Vol.160 (2), p.430-446

2019

Volltextzugriff (PDF)

Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming

Molecular cancer research, 2016-02, Vol.14 (2), p.141-162

2016

Volltextzugriff (PDF)

Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models

The journal of clinical endocrinology and metabolism, 2021-07, Vol.106 (7), p.1929-1955

2021

Volltextzugriff (PDF)

Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

Clinical cancer research, 2011-05, Vol.17 (9), p.2744-2756

2011

Volltextzugriff (PDF)

Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells

Cell cycle (Georgetown, Tex.), 2013-05, Vol.12 (9), p.1433-1449

2013

Volltextzugriff (PDF)

Progesterone Receptor–Cyclin D1 Complexes Induce Cell Cycle–Dependent Transcriptional Programs in Breast Cancer Cells

Molecular endocrinology (Baltimore, Md.), 2014-04, Vol.28 (4), p.442-457

2014

Volltextzugriff (PDF)

Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer

Endocrinology (Philadelphia), 2024-07, Vol.165 (9)

2024

Volltextzugriff (PDF)

Abstract POSTER-BIOL-1311: Mechanisms of differential activities of progesterone receptor (PR) isoforms in ovarian cancer models

Clinical cancer research, 2015-08, Vol.21 (16_Supplement), p.POSTER-BIOL-1311-POSTER-BIOL-1311

2015

Volltextzugriff (PDF)

Abstract 4752: Targeting senescence-induced pro-survival pathways in PR+ ovarian cancer cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4752-4752

2014

Volltextzugriff (PDF)

Glucocorticoid receptors are required effectors of TGF[beta]1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer

Breast cancer research : BCR, 2020-05, Vol.22 (1)

2020

Volltextzugriff (PDF)

Abstract 744: Progesterone receptors promote quiescence & ovarian cancer cell phenotypes via modulation of DREAM in p53-mutant fallopian tube models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.744-744

2021

Volltextzugriff (PDF)

Abstract 3084: Progesterone receptor mediated crosstalk between cancer associated fibroblasts (CAFs) and ER+/PR+ breast cancer cells through CAF-secreted FGF2

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3084-3084

2023

Volltextzugriff (PDF)

Abstract A39: FOXO1 is a key determinant of progesterone receptor isoform-specific senescence programming in ovarian cancer cells

Clinical cancer research, 2016-01, Vol.22 (2_Supplement), p.A39-A39

2016

Volltextzugriff (PDF)

Abstract 4050: Progesterone receptor signaling induces cellular senescence in ovarian cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4050-4050

2013

Volltextzugriff (PDF)

Synergistic effect between erlotinib and MEK inhibitors in KRAS wildtype human pancreatic cancer cells

Clinical cancer research, 2011-03, Vol.17 (9), p.2744-2756

2011

Volltextzugriff (PDF)

Abstract 1613: BTK as a drug target for cancers that harbor inactivating mutations in the DPC4 gene

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1613-1613

2010

Volltextzugriff (PDF)

Abstract B170: Downregulation of Yes-associated protein 1 (YAP1) expression reduces cell proliferation and clonogenicity of pancreatic cancer cells

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B170-B170

2009

Volltextzugriff (PDF)

Abstract 1338: Chemokine (CXC motif) Ligand 5 protein expression in pancreatic tumors: Exploring chemostatic gradients in the tumor microenvironment

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1338-1338

2010

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Female
(11)
Cell Line, Tumor
(10)
Receptors, Progesterone - Metabolism
(9)
Breast Cancer
(8)
Endocrinology & Metabolism
(6)
Phosphorylation
(6)
Progestin
(6)
Progesterone
(5)
Animals
(4)
Biochemistry & Molecular Biology
(4)
Breast Neoplasms - Metabolism
(4)
Gene Expression
(4)
Genetic Aspects
(4)
Kinases
(4)
Oncology
(4)
Progesterone Receptor
(4)
Transcription
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes

Progesterone action in breast, uterine, and ovarian cancers

Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells

Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for developing breast cancer

Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates

Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming

Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models

Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells

Progesterone Receptor–Cyclin D1 Complexes Induce Cell Cycle–Dependent Transcriptional Programs in Breast Cancer Cells

Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer

Abstract POSTER-BIOL-1311: Mechanisms of differential activities of progesterone receptor (PR) isoforms in ovarian cancer models

Abstract 4752: Targeting senescence-induced pro-survival pathways in PR+ ovarian cancer cells

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer

Glucocorticoid receptors are required effectors of TGF[beta]1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer

Abstract 744: Progesterone receptors promote quiescence & ovarian cancer cell phenotypes via modulation of DREAM in p53-mutant fallopian tube models

Abstract 3084: Progesterone receptor mediated crosstalk between cancer associated fibroblasts (CAFs) and ER+/PR+ breast cancer cells through CAF-secreted FGF2

Abstract A39: FOXO1 is a key determinant of progesterone receptor isoform-specific senescence programming in ovarian cancer cells

Abstract 4050: Progesterone receptor signaling induces cellular senescence in ovarian cancer cells

Synergistic effect between erlotinib and MEK inhibitors in KRAS wildtype human pancreatic cancer cells

Abstract 1613: BTK as a drug target for cancers that harbor inactivating mutations in the DPC4 gene

Abstract B170: Downregulation of Yes-associated protein 1 (YAP1) expression reduces cell proliferation and clonogenicity of pancreatic cancer cells

Abstract 1338: Chemokine (CXC motif) Ligand 5 protein expression in pancreatic tumors: Exploring chemostatic gradients in the tumor microenvironment

Suchergebnisse filtern